The development of a Wrist-Worn Reader is the latest advancement to the ID-Cap™ System, offering a promising solution to address the complex issue of medication non-adherence. Medication nonadherence is a widespread problem, resulting in...
Read moreNewsroom
ID-Cap™ System Powers Historic HIV Digital Pill Study
etectRx announces record-breaking use of the ID-Cap™ System, utilized in University of Colorado’s HIV treatment study. The Quantification of Tenofovir Alafenamide Adherence and Exposure in Adults living with HIV (QUANTI-TAF) study...
Read moreAARDEX® Group Adds etectRx to their MEMS® Adherence Hardware Ecosystem
The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in...
Read moreWHITEPAPER: The Extraordinary Problem of Medication Nonadherence in Oncology Patients And How Digital Pills Can Make a Difference
Cancer is often highly treatable due to new therapies, especially oral agents, that have improved outcomes and survival rates, and allow patients to be treated outside the hospital setting. Yet many patients fail to take their medication...
Read moreetectRx “It Already Does That”
Inspiration struck the etectRx team after watching the Apple Watch Series 6 – “It Already Does That” campaign. etectRx enthusiastically created its version of “It Already Does That” highlighting our FDA cleared ID-Cap™ System. We are...
Read moreThe ID-Cap™ System: A Physician’s Perspective
“The overall experience of our study participants so far with the ID-Cap System has been very positive. They have been able to navigate it quite easily and be engaged with the system.” – Dr. Jose Castillo-Mancilla, MD, Physician and Clinical...
Read moreDigital Pill Study Shows Significant Impact on Hepatitis C Treatment Adherence and Efficacy
A study conducted between August 2017 and April 2019 with 288 participants for hepatitis C virus (HCV) treatment evaluated the impact of a digital medicine program (DMP) on medication adherence (Proteus Digital Health) in a population at risk for...
Read moreFailure Risk in Clinical Trials? An Easy-to-Swallow Solution
Our CEO Valerie Sullivan speaks in PharmaVOICE about failing clinical trials and our easy solution: the etectRx digital pill ID-Cap™ System. With our technology, there is no reason for clinical trial failure, and with growing remote...
Read moreBetter Connections with Patients Using Data from Digital Pills
etectRx hosted an Xtalks Webinar on December 3: “Better Connections with Patients Using Data from Digital Pills.” Susan Baumgartner, VP of Product Management and Regulatory Affairs at etectRx, started the discussion speaking about medication...
Read moreThe ID-Cap™ System: A Patient’s Perspective
“I felt confident that the digital pill was safe, I knew it was effective. I didn’t have to worry about whether I could remember taking it and truly, it changed the way I approached my own health” – Court, 31 You asked...
Read morePharma Pro Brings Experience to Digital Pill Company – Orlando Medical News
CEO Valerie Sullivan spoke with Orlando Medical News about how her pharma experience will benefit etectRx as it continues to innovate medication adherence. Full Story
Read moreetectRx Launches First-Ever Virtual, Multi-Pill Clinical Trial Using Next-Generation ID-Tag
Late last week, we launched the first-ever virtual, multi-pill clinical trial to evaluate our ID-Cap™ System’s next-generation ingestible sensor, the ID-Tag 1.6. The ID-Cap System will allow our clinicians to utilize telehealth to remotely...
Read more